RESUMO
PURPOSE: Previous data demonstrated an increased incidence of Idiopathic Sensorineural Hearing Loss (ISSNHL) in 2021 compared to 2019-2020, suggesting an association with the anti-COVID-19 vaccine. We aimed to assess our center's incidence and compare the clinical manifestations and outcomes of vaccinated vs. unvaccinated patients. METHODS: A retrospective chart review of all patients diagnosed with ISSNHL during 2021 was conducted and compared to patients who presented in 2018-2020. Patient demographics, audiometry features, vaccination status, and prognosis were evaluated. RESULTS: Throughout 2021, 51 patients were diagnosed with ISSNHL, compared with 31 during 2020, 38 in 2019, and 41 in 2018, demonstrating a 64%, 34%, and 24% increase, respectively. Among patients who presented in 2021, 13 (25.4%) received the anti-COVID-19 vaccine within 30 days before their presentation, and 4 received it within 96 h. Most presented after receiving the second or third dose. Patient characteristics, audiometry features, and prognosis did not significantly differ between vaccinated and unvaccinated patients. CONCLUSIONS: A marked incline was seen in the 2021 ISSNHL incidence at our medical center, of which 25% of cases were within a month post-anti-COVID-19 vaccination. No significant difference was found in clinical manifestations and outcomes between vaccinated and nonvaccinated patients. While other justifications could be sought, an association cannot be ruled out, and further research is needed.
Assuntos
COVID-19 , Perda Auditiva Neurossensorial , Perda Auditiva Súbita , Vacinas , Humanos , Estudos Retrospectivos , COVID-19/epidemiologia , COVID-19/prevenção & controle , Prognóstico , Perda Auditiva Súbita/diagnóstico , Perda Auditiva Súbita/epidemiologia , Perda Auditiva Súbita/etiologia , Perda Auditiva Neurossensorial/diagnóstico , Perda Auditiva Neurossensorial/epidemiologia , Perda Auditiva Neurossensorial/etiologiaRESUMO
INTRODUCTION: Vestibular Schwannoma, a benign slow growing tumor on the eight cranial nerve, will eventually cause in most patients, a severe sensory neural hearing loss in the ipsilateral ear. Patients with asymmetric hearing loss experience difficulties in hearing in the presence of noise, in sound localization and an increase in listening effort, especially if contralateral hearing loss exists. Cochlear implant is the treatment of choice for hearing rehabilitation in severe to profound sensorineural hearing loss. This treatment was shown to be effective in patients with vestibular schwannoma whether they were treated by surgery, radiation or conservative surveillance only. In this case report we present 2 patients with stable growth of over 10 years, who presented with a severe decrease in hearing loss on the ipsilateral side and a known contralateral moderate loss. Both underwent cochlear implant with no other intervention and demonstrated great speech perception results and continue to use the implant regularly for several years. The cochlear implant is an effective tool for hearing rehabilitation for patients with a stable vestibular schwannoma under conservative surveillance. It is of grave importance to properly educate these patients on hearing rehabilitation and recommend cochlear implant for appropriate patients.
Assuntos
Implante Coclear , Implantes Cocleares , Surdez , Perda Auditiva Neurossensorial , Perda Auditiva , Neuroma Acústico , Percepção da Fala , Humanos , Implante Coclear/efeitos adversos , Implante Coclear/métodos , Neuroma Acústico/cirurgia , Neuroma Acústico/complicações , Perda Auditiva Neurossensorial/etiologia , Perda Auditiva Neurossensorial/cirurgia , Implantes Cocleares/efeitos adversos , Resultado do TratamentoRESUMO
PURPOSE: To evaluate the clinical course of children with acute mastoiditis (AM) who required surgical intervention. MATERIAL AND METHODS: Clinical and biochemical characteristics at the moment of hospital admission were reviewed for patients who required surgery for AM. Children who were successfully managed conservatively during the last 3 years of study were chosen as a comparison group. RESULTS: During 2008-2017, 570 children were admitted with AM: 82(14%) underwent cortical mastoidectomy, including 31(38%) with decompression of epidural space and sigmoid sinus. The comparison group consisted of 167 children with AM who did not require surgery. The surgical group had a higher rate of acute otitis media before admission. At the time of hospital admission, the surgical group had a higher rate of prolonged fever, otorrhea, and sub-periosteal abscess. Their average temperature, WBC, neutrophil count, and CRP were significantly higher (39.2 vs. 37.9°. C, 20 K vs. 16.5 K, 67 vs. 55.8 percent, 17 vs. 8.8, respectively, p = 0.0001). Fusobacterium necrophorum was the most common pathogen in the surgical group (50%), and group A streptococcus in the comparison group (22%). Sub-periosteal abscess, sinus venous thrombosis, and epidural involvement were diagnosed in 95, 35, and 38 percent of patients, respectively. Average length of IV antibiotic treatment was 20 days in operated children, compared to 5.6 days in the comparison group (p = 0.0001). Since 2013, a significantly higher percentage of children were diagnosed with Fusobacterium mastoiditis (p = 0.0001) who required surgery (p = 0.008). CONCLUSION: In children with AM presenting with, high fever, leukocytosis, elevated CRP, and sub-periosteal abscess, early CT and surgical intervention were frequently required. The increase in Fusobacterium infection might be an explanation for the increase in complicated AM requiring surgery.
Assuntos
Abscesso , Infecções por Fusobacterium , Fusobacterium necrophorum/isolamento & purificação , Mastoidectomia , Mastoidite , Complicações Pós-Operatórias , Abscesso/diagnóstico , Abscesso/microbiologia , Abscesso/cirurgia , Doença Aguda , Pré-Escolar , Tratamento Conservador/métodos , Descompressão Cirúrgica/métodos , Feminino , Infecções por Fusobacterium/fisiopatologia , Infecções por Fusobacterium/cirurgia , Humanos , Lactente , Israel , Masculino , Mastoidectomia/efeitos adversos , Mastoidectomia/métodos , Mastoidite/diagnóstico , Mastoidite/microbiologia , Mastoidite/fisiopatologia , Mastoidite/cirurgia , Avaliação de Processos e Resultados em Cuidados de Saúde , Seleção de Pacientes , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/microbiologia , Estudos Retrospectivos , Tomografia Computadorizada por Raios X/métodosRESUMO
BACKGROUND: Medullary thyroid carcinoma management consists mainly of surgical resection and is largely chemoresistant. There is ongoing effort to discover novel therapies for medullary thyroid carcinoma. Increased levels of heat shock proteins have been associated with multiple cancers and are being studied as potential therapeutic targets. The purpose of this study was to determine the expression levels of heat shock proteins 90 and 70 and of glucose related protein 78 in medullary thyroid carcinoma tissues compared with normal thyroid tissues. METHODS: 20 tissue specimens of medullary thyroid carcinoma and 10 specimens of thyroids without malignancy were analyzed by immunohistochemistry. RESULTS: Medullary thyroid carcinoma specimens showed 27% higher expression level of heat shock protein 90 immunostaining, and a 43% higher expression level of heat shock protein 70 immunostaining versus normal controls. These differences, however, were not statistically significant. A significantly higher expression level was noted for glucose related protein 78 in the medullary thyroid carcinoma specimens than in the controls. CONCLUSION: This study indicates increased expression levels of heat shock proteins 90 and 70 and glucose related protein 78 levels in medullary thyroid carcinoma. These findings, though preliminary imply that these proteins may have a role in medullary thyroid carcinoma's tumor biology and may have and future therapeutic options. Larger cohorts are needed to corroborate these results.
Assuntos
Carcinoma Neuroendócrino/metabolismo , Proteínas de Choque Térmico HSP70/metabolismo , Proteínas de Choque Térmico HSP90/metabolismo , Proteínas de Choque Térmico/metabolismo , Neoplasias da Glândula Tireoide/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Neuroendócrino/diagnóstico , Carcinoma Neuroendócrino/patologia , Criança , Chaperona BiP do Retículo Endoplasmático , Feminino , Humanos , Imuno-Histoquímica/métodos , Masculino , Pessoa de Meia-Idade , Neoplasias da Glândula Tireoide/diagnóstico , Neoplasias da Glândula Tireoide/patologia , Adulto JovemRESUMO
OBJECTIVE: Malignant external otitis (MEO) is an aggressive infection, primarily affecting elderly diabetic patients. It begins in the external ear canal and spreads to adjacent structures. This study investigated the clinical characteristics of patients diagnosed and treated for MEO and analyzed factors affecting patient outcomes. STUDY DESIGN: Historical cohort. SETTING: Tertiary medical center. METHODS: Medical records of all patients diagnosed and treated for MEO from 1990 to 2013, were retrospectively reviewed. Clinical features, laboratory, imaging and outcomes were analyzed. RESULTS: 88 patients were included, mean age was 73±11.5years, 61 (69%) were male. Of these, 75% had diabetes. Mean follow-up was 60months. The most common presenting symptoms were otalgia (89%), external ear canal edema (86%) and otorrhea (84%). Pseudomonas aeruginosa was isolated in 61% of ear cultures. All patients were treated with antibiotics, 22% had surgery and 8% hyperbaric oxygen. Overall survival rate was 38% in 5years, with disease specific mortality 14%. DM, facial nerve palsy, positive CT scan and age above 70 were found to correlate and predict disease-specific mortality. CONCLUSIONS: MEO carries a grave prognosis. The presence of two or more of the following features, DM, facial nerve palsy, positive CT scan and age above 70, predicts poor outcome, and highlights the need for prolonged, vigorous treatment.
Assuntos
Otite Externa/diagnóstico , Otite Externa/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Complicações do Diabetes/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Otite Externa/microbiologia , Prognóstico , Estudos Retrospectivos , Fatores de Risco , Taxa de SobrevidaRESUMO
BACKGROUND: Treatment guidelines for well-differentiated papillary thyroid carcinoma (PTC) are based on retrospective studies and vary among professional thyroid associations. OBJECTIVES: To evaluate physician adherence to guidelines, overall and by specialty. METHODS: Questionnaires on the approach to low risk PTC were distributed among 51 surgeons and endocrinologists treating patients with PTC in tertiary medical centers. RESULTS: A wide range of answers was recorded among physicians regarding the danger posed by low risk PTC to the patient's life, urgency with which treatment should be administered, type of treatment, and risks associated with this treatment. There was a significant between-group difference in treatment preference: endocrinologists chose total thyroidectomy with radioactive iodine, while surgeons favored hemithyroidectomy alone. CONCLUSIONS: There is a wide difference in treatment recommendations between treating physicians and different specialties with regard to low risk PTC. The wide variation within and between soecialties may be explained by biases.
Assuntos
Carcinoma , Endocrinologia/métodos , Cirurgia Geral/métodos , Radioisótopos do Iodo/uso terapêutico , Radioterapia Adjuvante/métodos , Neoplasias da Glândula Tireoide , Tireoidectomia , Atitude do Pessoal de Saúde , Carcinoma/diagnóstico , Carcinoma/terapia , Carcinoma Papilar , Fidelidade a Diretrizes/estatística & dados numéricos , Pesquisas sobre Atenção à Saúde , Humanos , Israel , Gradação de Tumores , Guias de Prática Clínica como Assunto , Risco Ajustado/métodos , Inquéritos e Questionários , Câncer Papilífero da Tireoide , Glândula Tireoide/patologia , Glândula Tireoide/cirurgia , Neoplasias da Glândula Tireoide/diagnóstico , Neoplasias da Glândula Tireoide/terapia , Tireoidectomia/efeitos adversos , Tireoidectomia/métodosRESUMO
"Endoscopic ear surgery (EES) has become increasingly popular due to numerous visualization benefits, including angled optics that enable the surgeon to see and dissect around corners. These advantages help the surgeon overcome the visualization limitations of microscopic ear surgery, reducing the need for a post-auricular incision and bone removal. This chapter discusses useful pearls and pitfalls of EES, technical tips and ergonomic strategies, so the learner can understand and solve common obstacles faced when learning EES and incorporate it into his or her practice."
Assuntos
Orelha Média/cirurgia , Endoscopia/métodos , Procedimentos Cirúrgicos Otológicos/métodos , HumanosRESUMO
OBJECTIVE: To compare surgical characteristics and complications between well drilling (WD) and subperiosteal pocket techniques (SPT) for receiver/stimulator (R/S) fixation of cochlear implant (CI), and conduct cost-effectiveness analysis. STUDY DESIGN: Retrospective clinical study, decision-analysis model. SETTING: Tertiary referral center. PATIENTS: Three-hundred and eighty-eight CI recipients with a minimum of 6-months follow-up. INTERVENTIONS: CI surgery using either WD or SPT for R/S fixation. A decision-analysis model was designed using data from a systematic literature review. MAIN OUTCOME MEASURES: Surgical operation time, rates of major and minor long-term complications were compared. Incremental cost-effectiveness was also estimated, comparing the two methods of fixation. RESULTS: We compared 179 WD with 209 SPT. Surgery time was significantly shorter in SPT (148 versus 169âmin, pâ=â0.001) and remained significant after adjustment for possible confounders. Higher rates of major complications requiring surgical intervention were found with SPT (10.5% versus 4.5%, pâ=â0.042), however, the difference was not significant after adjusting for follow-up time (47.8 versus 32.5 months for SPT, WD respectively; pâ<â0.001). The incremental cost-effectiveness ratio for WD (compared with SPT) was $48,795 per major complication avoided, which was higher than the willingness-to-pay threshold of $47,700 (average cost of 2âh revision surgery). CONCLUSIONS: SPT was found to be faster but potentially risks more complications, particularly relating to device failure. Further long-term studies are required to validate these differences. Based on data from the current literature, neither of the methods is compellingly cost-effective over the other, and surgeons can base their choice on personal preference, comfort, and previous training.
Assuntos
Implante Coclear , Implantes Cocleares , Estudos de Casos e Controles , Análise Custo-Benefício , Humanos , Estudos RetrospectivosRESUMO
OBJECTIVE: To review occupational ergonomic risks for the Otologist and Neurotologist. DATA SOURCES: MEDLINE, OVID, PubMed, and Google Scholar. STUDY SELECTION: A search was conducted to identify all studies in the English language that involve ergonomic-related risks for surgeons. RESULTS: Occupational hazards, particularly musculoskeletal disorders (MSDs), are common in the surgical community in general and among Otolaryngologists in particular. Very few studies have been conducted assessing MSDs specific to Otologists and Neurotologists. However, extrapolating from other surgical professions with similar ergonomic postures in the operation room and office, one can infer that cervical and lumbar pain are related to prolonged static sitting and neck flexion when working with a microscope and begins early in training. Early institution of correct ergonomic training is feasible and may be effective. Improved ergonomic habits include upright sitting, avoidance of neck flexion, initiating short breaks, and the use of chairs with arm and back support. Future technologies incorporated into otologic surgery should have improved ergonomic design. CONCLUSIONS: Otologists and Neurotologists are exposed to MSDs directly related to their work demands. Incorporating healthy ergonomics into surgical training as well adopting correct posture and the use equipment designed for back support may help mitigate the long-terms risks of MSD.
Assuntos
Ergonomia , Doenças Musculoesqueléticas , Doenças Profissionais , Humanos , Doenças Musculoesqueléticas/etiologia , Doenças Musculoesqueléticas/prevenção & controle , Doenças Profissionais/etiologia , Doenças Profissionais/prevenção & controle , Otorrinolaringologistas , PosturaRESUMO
HYPOTHESIS: Three-dimensional (3D)-printed microneedles can create precise holes on the scale of micrometers in the human round window membrane (HRWM). BACKGROUND: An intact round window membrane is a barrier to delivery of therapeutic and diagnostic agents into the inner ear. Microperforation of the guinea pig round window membrane has been shown to overcome this barrier by enhancing diffusion 35-fold. In humans, the challenge is to design a microneedle that can precisely perforate the thicker HRWM without damage. METHODS: Based on the thickness and mechanical properties of the HRWM, two microneedle designs were 3D-printed to perforate the HRWM from fresh frozen temporal bones in situ (nâ=â18 total perforations), simultaneously measuring force and displacement. Perforations were analyzed using confocal microscopy; microneedles were examined for deformity using scanning electron microscopy. RESULTS: HRWM thickness was determined to be 60.1â±â14.6 (SD) µm. Microneedles separated the collagen fibers and created slit-shaped perforations with the major axis equal to the microneedle shaft diameter. Microneedles needed to be displaced only minimally after making initial contact with the RWM to create a complete perforation, thus avoiding damage to intracochlear structures. The microneedles were durable and intact after use. CONCLUSION: 3D-printed microneedles can create precise perforations in the HRWM without damaging intracochlear structures. As such, they have many potential applications ranging from aspiration of cochlear fluids using a lumenized needle for diagnosis and creating portals for therapeutic delivery into the inner ear.
Assuntos
Agulhas , Janela da Cóclea , Animais , Cóclea , Cobaias , Humanos , Impressão Tridimensional , Janela da Cóclea/diagnóstico por imagem , Janela da Cóclea/cirurgiaRESUMO
OBJECTIVE: Imaging is important for the diagnosis and follow-up of necrotizing external otitis (NEO). The best imaging modality is controversy. To suggest 2-deoxy-2-[fluorine-18] fluoro-D-glucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) as an alternative to technetium-99m and gallium-67 scans for diagnosis and assessment of response to treatment for patients with NEO. STUDY DESIGN: Case series. METHODS: Tertiary referral center. From 2013 through 2017, 12 patients were diagnosed with NEO based on clinical features and positive FDG uptake within the temporal bone on PET/CT. Mean age was 74 ± 11.5; 83% of the patients were male; and 83% had diabetes. RESULTS: PET/CT scans were reviewed independently by two nuclear medicine specialists. Imaging located osteomyelitis in external ear canal, mastoid, temporomandibular joint, and nasopharyngeal region (100%, 50%, 16%, 8%, respectively). Mean follow-up was 16 months. Eight patients (67%) underwent a second PET/CT scan after active otitis resolved and after at least 6 weeks of antibiotic treatment. The scan demonstrated no or substantially reduced FDG uptake and treatment was stopped. The patients had no NEO symptoms at the end of follow-up. One patient had significant uptake, and antibiotic treatment was continued until a third scan demonstrated no FDG uptake. Two patients died before the second PET/CT, and two were lost to follow-up. CONCLUSION: 18F-FDG-PET/CT is a reliable imaging modality for diagnosis, disease localization, and decision making regarding treatment cessation. 18F-FDG-PET/CT should be considered as the imaging modality of choice for initial diagnosis and follow-up in NEO patients. Larger, controlled studies are warranted. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:961-966, 2019.
Assuntos
Fluordesoxiglucose F18 , Otite Externa/diagnóstico por imagem , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Compostos Radiofarmacêuticos , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Necrose/diagnóstico por imagem , Otite Externa/patologia , Otite Externa/terapia , Estudos RetrospectivosRESUMO
BACKGROUND: Packing of the middle meatus and ethmoid cavities is a common practice in endoscopic sinus surgery (ESS), but its necessity recently has been challenged. The aim of this study was to formulate a decision-analysis model to determine the need for packing in ESS and identify variables affecting the decision. METHODS: A systematic review of the literature was conducted for all randomized control trials comparing packing to no packing in ESS, and a decision-analysis model was generated. Probabilities and utilities were derived from the literature. Sensitivity analysis was used to determine which variables most affected the model. RESULTS: No packing was associated with better expected utilities than packing. On sensitivity analysis, packing was preferred when the disutility of no packing outweighed the disutility of packing, and when the probability for synechiae was greater than 35% without packing or lower than 2% with packing. When the component of packing removal was subtracted from the overall disutility simulating absorbable packing, the results favored packing. CONCLUSION: Our decision-analysis model indicates that middle meatal packing is not advantageous for patients undergoing ESS. Absorbable packing materials have a less adverse effect on quality of life than nonabsorbable materials. LEVEL OF EVIDENCE: 1a. Laryngoscope, 127:1506-1512, 2017.
Assuntos
Técnicas de Apoio para a Decisão , Endoscopia/métodos , Seios Paranasais/cirurgia , Rinite/cirurgia , Sinusite/cirurgia , Adulto , Árvores de Decisões , Medicina Baseada em Evidências , Humanos , Obstrução Nasal/etiologia , Obstrução Nasal/prevenção & controle , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/prevenção & controle , Hemorragia Pós-Operatória/etiologia , Hemorragia Pós-Operatória/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto , Software , Tampões CirúrgicosAssuntos
Implante Coclear , Implantes Cocleares , Surdez , Análise Custo-Benefício , Surdez/cirurgia , HumanosAssuntos
Implante Coclear/métodos , Implantes Cocleares/economia , Análise Custo-Benefício/estatística & dados numéricos , Surdez/cirurgia , Implante Coclear/economia , Implante Coclear/estatística & dados numéricos , Implantes Cocleares/estatística & dados numéricos , Humanos , Anos de Vida Ajustados por Qualidade de Vida , Resultado do TratamentoAssuntos
Neoplasias da Orelha/diagnóstico por imagem , Imageamento por Ressonância Magnética/métodos , Otite Externa/diagnóstico por imagem , Compostos Radiofarmacêuticos , Tomografia Computadorizada por Raios X/métodos , Antibacterianos/uso terapêutico , Neoplasias da Orelha/terapia , Radioisótopos de Gálio , Humanos , Otite Externa/terapia , Medronato de Tecnécio Tc 99mRESUMO
IMPORTANCE: Anaplastic thyroid carcinoma is an undifferentiated aggressive tumor with a high rate of regional and distant spread and a grave prognosis (median survival, 3 months) with no standardized treatment. OBJECTIVE: To review the effect of an active treatment policy on the outcome of anaplastic thyroid carcinoma. DESIGN, SETTING, AND PARTICIPANTS: Retrospective comparative study of all patients diagnosed as having anaplastic thyroid carcinoma and undergoing treatment from January 1, 2008, through December 31, 2013, in a tertiary university-affiliated medical center. Data were collected by medical record review. Final follow-up was completed on November 30, 2014. Data were analyzed from December 1 to 3, 2014. INTERVENTIONS: Treatment options included surgery and adjuvant concomitant radiotherapy and chemotherapy with doxorubicin hydrochloride or paclitaxel for local disease; full-dose chemoradiotherapy (70 Gy to the gross tumor) for local disease when surgery was not feasible; aggressive palliative radiotherapy (50 Gy to the gross tumor) for metastatic disease; and palliative radiotherapy (≤ 30 Gy) for metastatic disease with a low performance status. MAIN OUTCOMES AND MEASURES: Survival time and quality of life. RESULTS: Of the 26 patients (including 15 women) who met the inclusion criteria, 11 underwent radiotherapy with curative intent. These patients included 5 who underwent curative surgery (5 with chemotherapy) and 6 who received primary chemotherapy. Nine patients received aggressive palliative radiotherapy, and 3 received palliative radiotherapy. The remaining 3 patients were not treated. Curative radiotherapy was associated with a significantly longer overall median (95% CI) survival time (11 [8.1-13.9] months) than aggressive palliative radiotherapy (6 [3.1-8.9] months), palliative radiotherapy (3 [0.0-7.8] months), and no treatment (1 month) (P < .001). Chemotherapy in 10 patients had a significant effect on survival (mean [95% CI], 11 [1.2-6.8] vs 4 [8.1-13.9] months for patients who did not receive chemotherapy; P = .01). Among the patients who underwent surgery and curative radiotherapy, 3 were alive after more than 3 years of follow-up. No association of survival with patient sex (median [95% CI] survival for men and women, 9 [3.6-14.4] and 5 [0.3-9.7] months, respectively; P = .54) or a history of thyroid disease (median [95% CI] survival for those with and without, 4 [1.0-6.9] and 9 [5.4-12.5] months, respectively; P = .15) was found. CONCLUSIONS AND RELEVANCE: Anaplastic thyroid carcinoma has a grave prognosis, but an aggressive approach, including surgery, chemotherapy, and radiotherapy, seems to improve survival. Higher doses of radiotherapy may have a survival benefit in candidates for palliative treatment and may be considered for patients with extensive disease.